NEW YORK (GenomeWeb) – Qiagen said in a filing with the US Securities and Exchange Commission today that it paid $114.2 million in cash consideration to acquire Enzymatics' enzyme solutions unit in December 2014.

The firm said that $11.5 million was retained in an escrow account to cover any claims for breach of any representations, warranties, or indemnities.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

In Science this week: analysis of DNA from ancient North Africans, and more.